CYCLACEL PHARMACEUTICALS INC (CYCC)       1.25  +0.01 (+0.81%)

1.25  +0.01 (+0.81%)

US23254L6039 - Common Stock

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 -0.46 -0.64 0.1827.87% Q1 2022 -0.42 -0.70 0.2839.82% Q4 2021 -0.54 -0.67 0.1318.97% Q3 2021 -0.54 -0.66 0.1218.55% Q2 2021 -0.56 -0.51 -0.05-10.54% Q1 2021 -0.50 -0.50 0.00-0.72% Q4 2020 -1.34 -0.53 -0.81-155.09% Q3 2020 -0.47 -0.56 0.0916.22%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -2.09 -2.14 2.45%Q3 2022 -0.58 -0.54 -7.67%Q4 2022 -0.59 -0.54 -8.93%FY 2023 -2.63 -2.09 -25.90%Q1 2023 -0.71 -0.42 -70.00%Q2 2023 -0.45 -0.46 2.43%Q3 2023 -1.00 -0.58 -71.93%Q4 2023 -1.10 -0.59 -87.28%FY 2024 -3.02 -2.63 -14.88%FY 2025 -2.36 -3.02 21.95%FY 2026 -1.88 -2.36 20.39%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 % Q1 2022 % Q4 2021 % Q3 2021 % Q2 2021 % Q1 2021 % Q4 2020 % Q3 2020 %
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 %Q3 2022 %Q4 2022 %FY 2023 %Q1 2023 %Q2 2023 %Q3 2023 %Q4 2023 %FY 2024 %FY 2025 %FY 2026 %